Manufacturer record
NuGen Healthcare: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by NuGen Healthcare (Chandigarh) was declared Not of Standard Quality in August 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: NHC-5C004C, Rabeprazole sodium (Enteric Coated) & Domperidone (Sustained Release) Capsules. (exp Feb 2027). State Drugs Laboratory, Punjab (state lab) found it not of standard quality: The contents of Rabeprazole Sodium found to be 16.57mg/per capsule (82.85%) against labelled claim of 20 mg per capsule. Listed in the August 2025 alert.
Records by type
1 record linked to NuGen Healthcare in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rabeprazole sodium (Enteric Coated) & Domperidone (Sustained Release) Capsules. | Batch NHC-5C004CMfg Mar 2025 · Exp Feb 2027 | The contents of Rabeprazole Sodium found to be 16.57mg/per capsule (82.85%) against labelled claim of 20 mg per capsule.Labelling | State Drugs Laboratory, PunjabState lab | Aug 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.